<DOC>
	<DOCNO>NCT01098552</DOCNO>
	<brief_summary>This research study do collect regular routine follow-up information relate outcome treatment prostate cancer . This study also do relate treatment outcome measurement substance blood prostate-specific antigen ( PSA ) marker . Also environmental genetic factor might responsible prostate cancer investigate .</brief_summary>
	<brief_title>Participation Procurement Tissue , Serum , Plasma , Cell Bank , DNA RNA Samples , Urine Biological Studies Related Prostate Cancer Prostate Cancer Treatment Follow Up</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Informed consent explain sign prior study related procedure . 2 . Age â‰¥18 year 3 . Eastern Cooperative Oncology Group ( ECOG ) performance status 2 good , Karnofsky performance 60 % good . 4 . Histologically confirm adenocarcinoma prostate within 10 year study entry . 5 . Willingness return Mayo Clinic Rochester followup participate mailin PSA processing . 6 . Must diseasefree previous diagnosis cancer period time = 5 year exclude cutaneous malignancy squamous cell basal cell carcinoma . 1 . Life expectancy &lt; 5 year . 2 . Inability return Mayo Rochester followup appointment , serum , urine collection per protocol . 3 . Previous concurrent diagnosis cancer basal cell invasive squamous cell carcinoma skin within past 5 year .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Prostate Cancer</keyword>
</DOC>